Nanoscience Technologies, Inc. Appoints David Keenan to President and Chief Executive Officer

NEW YORK--(BUSINESS WIRE)--Sept. 27, 2005--Nanoscience Technologies, Inc. (OTCBB:NANS) announced the appointment of David Keenan, 49, to President and CEO. In his new role with the Company Mr. Keenan will assume responsibility for all operating venues and focus on developing corporate research & development partnerships and identifying licensing opportunities for the area of DNA nanotechnology. NTI holds the worldwide exclusive licensing rights to the intellectual property of Dr. Nadrian Seeman, Professor of Chemistry at New York University.

Mr. Keenan is well versed in the nanotechnology arena and has significant experience in developing markets for technical products. He has previously served as Business Development Manager, Advanced MicroMachines, a business within Goodrich Corporation's Sensor Systems Division. Prior to his role at Goodrich he worked with Sheldahl, Inc., a prime supplier of thermal controls for spacecraft, and for over a decade worked with the 3M Company in the area of optical recording discs. Mr. Keenan stated, "We intend on moving rapidly to align ourselves with significant corporate research partners in the nano arena and we will aggressively pursue initial licensing arrangements for the wide array of DNA nanotechnology tools emerging through our licensing rights for the fabrication and manufacturing world." David Rector, the former President and CEO of NTI, will assume the post of Chief Operating Officer.

“We intend on moving rapidly to align ourselves with significant corporate research partners in the nano arena and we will aggressively pursue initial licensing arrangements for the wide array of DNA nanotechnology tools emerging through our licensing rights for the fabrication and manufacturing world.”

Mr. Keenan holds a BS in Chemical Engineering from the University of Wisconsin and an MS Management Technology from the University of Minnesota. He presents regularly to the Minnesota Nanotechnology Study Group and provides editorial input for the The NanoTechnology Group webzine.

For a complete transcript of this release please go to the Nanoscience Technologies, Inc. company website at: http://www.nanoscience-tech.com.

Contacts

Nanoscience Technologies, Inc., New York
David Keenan, 212-332-3443
or
Maplehurst Capital Corporation
Investor Relation Contact: 917-838-3991

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.